TY - JOUR A2 - Su, Ting AU - Zhao, Sidi AU - Shi, Shuangshuang AU - Yang, Wanchen AU - Wang, Hanqing AU - Jian, Tianming AU - He, Qing AU - Liu, Yang AU - Huang, Xiaoming AU - Wu, Tong PY - 2022 DA - 2022/07/29 TI - RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves' Ophthalmopathy SP - 8323946 VL - 2022 AB - During Graves' disease (GD) treatment, Graves' ophthalmopathy (GO) is often ignored because only mild ocular symptoms are present in early GD.并测量相关内分泌激素以确定GO预处理因子GD和GO3名病人的血清样本和GD3名病人的GD但没有GO则由itraQ分析基于临床数据,60名GD病人划分成GO免GO组和GO组所有病人跟踪7个月记录他们的眼状况和生物化学索引变化iTRAQ显示RhoA表达式调高并显著关联到紧接线路径和免责FT3和RhoA从基数改为7个月,FT3和RhoA基线水平,GD病人TRAB顶级水平在各组间大相径庭ELISA和Western染色体RhoA、TRAB和FT3从GO病人血清样本中显示显著提高调控,高血清RhoA和TRAB水平介于GO温和阶段7个月时血清RhoA和FT3水平提高RhoA为温和GO提供潜在生物标志GD病人中,如果高血清RhoA级配有高TRAB或FT3级,GO极有可能发生,即使没有显眼症状。SN-0278-0240UR-https://doi.org/101155/2022/8323946DO-10.115502022/8323946JF-Draps markersPB-HindawiKW-ER